|
small
font | large font
To print PDF version, click here.
Menactra™ - Meningococcal Vaccine
(groups A, C, Y and
W-135 conjugate)
What is meningococcal disease?
• Meningococcal disease is a serious illness caused by a
bacteria. It can produce an infection of the blood or an
infection of the lining of the brain and spinal cord
(meningitis).
• Meningococcal disease is spread by nasal droplets and
throat secretions.
• Between 5 and 15% of people who get this disease will
die; 25% of these deaths are in children.
What does meningococcal vaccine contain?
• Meningococcal vaccine contains diphtheria toxoid protein,
sodium chloride, sodium phosphate and water for
injection.
• No preservative or adjuvant is added during manufacture.
• The stopper of the meningococcal vial contains latex. The
syringe presentation contains no latex.
Who should receive the vaccine?
• People 2 years of age and older.
• College freshmen who live in dorms.
• Lab personnel who are routinely exposed to isolates of N.
meningitides.
Who should not receive the vaccine?
• Children under the age of 2.
• Anyone who has had a life-threatening allergic reaction to
any component of the vaccine.
• Use with caution for pregnant or breastfeeding women.
• People with moderate to severe illness may have to delay
immunization.
• People with a known history of Guillain-Barré syndrome.
When should the vaccine be given?
• At least two weeks before international travel.
• One dose for people 2 years of age and older.
• At least 10 to 14 days before removal of spleen.
• May be safely given with other vaccines.
How is the vaccine given?
• By injection into a muscle.
How effective is the vaccine?
• Over 80% of children aged 2 to 20 years are protected.
• Over 90% of people 11 years and older are protected.
How long does the protection last?
• At least 2 to 3 years.
• Duration of protection is unknown.
What might be felt after receiving the vaccine?
• Pain
• Redness
• Swelling
• Diarrhea
• Appetite changes
• Achiness
• Fever
• Vomitting
Call the number below if you have severe or unusual reactions.
For more information contact Public Health Services at (306) 655-4780.
© 2008, Saskatoon Health Region. Reproduced only by permission.
(updated February 19, 2009)
|